Skip to content
Trial Eligibility
Menu

Clinical Outcomes Study of the Nexel Total Elbow

NCT02469662

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Elbow Joint Destruction
  • Post-traumatic Lesions
  • Ankylosed Joints
  • Advanced Rheumatoid Arthritis
  • Joint Instability or Loss of Motion
  • Acute Comminuted Articular Fracture of Elbow Joint Surfaces
  • Bone Loss Contributing to Elbow Instability
  • Bilateral Ankylosis From Causes Other Than Active Sepsis
  • Post-traumatic Arthritis
  • Degenerative Arthritis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Zimmer Biomet
Last updated on ClinicalTrials.gov
July 9, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Panorama Orthopedics and Spine Center · Golden, CO

North Carolina · 1

  • OrthoCarolina Research Institute · Charlotte, NC

Pennsylvania · 1

  • Rothman Institute · Philadelphia, PA

Tennessee · 1

  • Campbell Clinic · Germantown, TN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.